在退伍军人健康管理局接受治疗的越战退伍军人中前列腺癌的发病率和结果

IF 5.1 2区 医学 Q1 ONCOLOGY
Cancer Pub Date : 2025-07-18 DOI:10.1002/cncr.70007
Ashley-Marie Y. Green-Lott MD, Ananta Wadhwa BS, Anissa V. Bailey MPH, Lorna Kwan MPH, Candace L. Haroldsen MSPH, Jeremy B. Shelton MD, MSHS, Michael S. Lewis MD, David O. Beenhouwer MD, Karim Chamie MD, Brent S. Rose MD, Kara N. Maxwell MD, PhD, Nicholas G. Nickols MD, PhD, Kosj Yamoah MD, PhD, Michael J. Kelley MD, Timothy R. Rebbeck PhD, Martin Schoen MD, MPH, Matthew B. Rettig MD, Hari S. Iyer ScD, Isla P. Garraway MD, PhD
{"title":"在退伍军人健康管理局接受治疗的越战退伍军人中前列腺癌的发病率和结果","authors":"Ashley-Marie Y. Green-Lott MD,&nbsp;Ananta Wadhwa BS,&nbsp;Anissa V. Bailey MPH,&nbsp;Lorna Kwan MPH,&nbsp;Candace L. Haroldsen MSPH,&nbsp;Jeremy B. Shelton MD, MSHS,&nbsp;Michael S. Lewis MD,&nbsp;David O. Beenhouwer MD,&nbsp;Karim Chamie MD,&nbsp;Brent S. Rose MD,&nbsp;Kara N. Maxwell MD, PhD,&nbsp;Nicholas G. Nickols MD, PhD,&nbsp;Kosj Yamoah MD, PhD,&nbsp;Michael J. Kelley MD,&nbsp;Timothy R. Rebbeck PhD,&nbsp;Martin Schoen MD, MPH,&nbsp;Matthew B. Rettig MD,&nbsp;Hari S. Iyer ScD,&nbsp;Isla P. Garraway MD, PhD","doi":"10.1002/cncr.70007","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.</p>\n </section>\n </div>","PeriodicalId":138,"journal":{"name":"Cancer","volume":"131 15","pages":""},"PeriodicalIF":5.1000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70007","citationCount":"0","resultStr":"{\"title\":\"Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration\",\"authors\":\"Ashley-Marie Y. Green-Lott MD,&nbsp;Ananta Wadhwa BS,&nbsp;Anissa V. Bailey MPH,&nbsp;Lorna Kwan MPH,&nbsp;Candace L. Haroldsen MSPH,&nbsp;Jeremy B. Shelton MD, MSHS,&nbsp;Michael S. Lewis MD,&nbsp;David O. Beenhouwer MD,&nbsp;Karim Chamie MD,&nbsp;Brent S. Rose MD,&nbsp;Kara N. Maxwell MD, PhD,&nbsp;Nicholas G. Nickols MD, PhD,&nbsp;Kosj Yamoah MD, PhD,&nbsp;Michael J. Kelley MD,&nbsp;Timothy R. Rebbeck PhD,&nbsp;Martin Schoen MD, MPH,&nbsp;Matthew B. Rettig MD,&nbsp;Hari S. Iyer ScD,&nbsp;Isla P. Garraway MD, PhD\",\"doi\":\"10.1002/cncr.70007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.</p>\\n </section>\\n </div>\",\"PeriodicalId\":138,\"journal\":{\"name\":\"Cancer\",\"volume\":\"131 15\",\"pages\":\"\"},\"PeriodicalIF\":5.1000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cncr.70007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cncr.70007\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cncr.70007","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

橙剂暴露(AOE)被认为是退伍军人事务部(VA)人群前列腺癌(PCa)的推定原因;然而,队列研究报告了AOE与PCa发病率和结局之间不一致的关联。在这项全国性的队列研究中,对接受退伍军人护理的越南退伍军人进行了AOE和PCa发病率以及不良结果的关联评估。方法选取2005 - 2020年间接受退伍军人管理局医疗保健的17-25岁越战退伍军人(1962-1971),按退伍军人管理局指定的推定AOE进行分层,随访至2023年9月31日因任何原因死亡或审查死亡。多变量Cox模型允许估计AOE与PCa发病率、新发转移(DNM)、任何转移、转移性去势抵抗性PCa (mCRPC)、全因死亡率(ACM)或PCa特异性死亡率(PCSM)的校正风险比(aHRs)。结果在260万有PCa风险的越南退伍军人中,779,472人(30%)有AOE。与未暴露的退伍军人相比,AOE退伍军人患PCa的风险更高(aHR, 1.15;95%可信区间[CI], 1.15-1.16),较高的DNM (aHR, 1.17;95% CI, 1.16-1.17),任何转移(aHR, 1.17;95% CI, 1.16-1.17), mCRPC (aHR, 1.17;95% CI, 1.16-1.17), ACM (aHR, 1.41;95% CI, 1.41-1.42)和PCSM (aHR, 1.17;95% CI, 1.16-1.17)。敏感性分析表明AOE与全因死亡率之间的相关性具有稳健性,但选择偏倚可以解释与PCa结果的相关性。结论:推定的AOE与较高的PCa发病率、死亡率和不良结局相关。虽然联系可能不是因果关系,但AOE可能预示着退伍军人事务中较差的PCa结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

Background

Agent Orange exposure (AOE) is considered a presumptive cause of prostate cancer (PCa) in the Veterans Affairs (VA) population; however, cohort studies reported inconsistent associations of AOE and PCa incidence and outcomes. In this nationwide cohort study, Vietnam veterans who received VA care were evaluated for associations of AOE and PCa incidence and adverse outcomes.

Methods

Vietnam veterans 17–25 years old during military service (1962–1971) who received VA health care between 2005 and 2020 were stratified by presumptive AOE assigned by the VA and followed until death from any cause or censoring on September 31, 2023. Multivariable Cox models permitted estimation of adjusted hazard ratios (aHRs) of AOE with PCa incidence, de novo metastasis (DNM), any metastasis, metastatic castration-resistant PCa (mCRPC), all-cause mortality (ACM), or PCa-specific mortality (PCSM).

Results

Among 2.6 million Vietnam veterans at risk for PCa, 779,472 (30%) had AOE. Compared to unexposed veterans, AOE veterans had higher PCa risk (aHR, 1.15; 95% confidence interval [CI], 1.15–1.16), higher DNM (aHR, 1.17; 95% CI, 1.16–1.17), any metastasis (aHR, 1.17; 95% CI, 1.16–1.17), mCRPC (aHR, 1.17; 95% CI, 1.16–1.17), ACM (aHR, 1.41; 95% CI, 1.41–1.42), and PCSM (aHR, 1.17; 95% CI, 1.16–1.17) in adjusted models. Sensitivity analyses suggested robustness of association between AOE and all-cause mortality, but selection bias could explain associations with PCa outcomes.

Conclusions

Presumptive AOE was associated with higher PCa incidence, mortality, and adverse outcomes. Although associations may not be causal, AOE may predict worse PCa outcomes in the Veterans Affairs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer
Cancer 医学-肿瘤学
CiteScore
13.10
自引率
3.20%
发文量
480
审稿时长
2-3 weeks
期刊介绍: The CANCER site is a full-text, electronic implementation of CANCER, an Interdisciplinary International Journal of the American Cancer Society, and CANCER CYTOPATHOLOGY, a Journal of the American Cancer Society. CANCER publishes interdisciplinary oncologic information according to, but not limited to, the following disease sites and disciplines: blood/bone marrow; breast disease; endocrine disorders; epidemiology; gastrointestinal tract; genitourinary disease; gynecologic oncology; head and neck disease; hepatobiliary tract; integrated medicine; lung disease; medical oncology; neuro-oncology; pathology radiation oncology; translational research
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信